Modulators of G-Protein Coupled Receptors
US-2024383960-A1 · Nov 21, 2024 · US
This page is not indexed by search engines while we improve data quality.
Erlanson Daniel patents
Erlanson Daniel is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Erlanson Daniel |
| Total patents | 12 |
| First publication | Nov 17, 2016 |
| Latest publication | Nov 21, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic compounds useful as pdk1 inhibitors
US-2024294524-A1 · Sep 5, 2024 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2023113598-A1 · Apr 13, 2023 · US
N-cyano-7-azanorbornane derivatives and uses thereof
US-11572374-B2 · Feb 7, 2023 · US
N-cyano-7-azanorbornane derivatives and uses thereof
US-2022363694-A1 · Nov 17, 2022 · US
KRAS G12C inhibitors and methods of using the same
US-11053226-B2 · Jul 6, 2021 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2021070752-A1 · Mar 11, 2021 · US
Kras g12c inhibitors and methods of using the same
US-2020165231-A1 · May 28, 2020 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2019119268-A1 · Apr 25, 2019 · US
Heterocyclic compounds useful as PDK1 inhibitors
US-10030016-B2 · Jul 24, 2018 · US
Recent patents
Latest publications not already listed above.
Heterocyclic compounds useful as PDK1 inhibitors
US-9546165-B2 · Jan 17, 2017 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2016331756-A1 · Nov 17, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Millennium Pharm Inc | 7 |
| Sunesis Pharmaceuticals Inc | 5 |
| Amgen Inc | 4 |
| Carmot Therapeutics Inc | 3 |
| Viracta Therapeutics Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D471/04 | 9 |
| C07D413/14 | 9 |
| A61P35/00 | 9 |
| A61K31/4427 | 9 |
| C07D498/04 | 9 |